Top Tweets for #SKBioscience
$NVAX
➡️ profitable
➡️ $751M CASH
➡️ $1.2B investment #Sanofi $SNY
➡️ $553M investment #Pfizer $PFE
➡️ #MatrixM adjuvant in mostly widely used #Malaria vaccine
➡️ partners w/ @SerumInstIndia
➡️ partners w/ #CornellUniversity
➡️ partners w/ #Skbioscience
➡️ Current MC= $1.68B
If #ShahCapital escalates activism or short covering intensifies, it could pressure a deal—potentially with #Sanofi or rivals like #Pfizer
4 entities own 19.25% of #Novavax
#Sanofi owns 4.9%
#ShahCapital owns 8.95%
#SKbioscience owns 3.9%
#Insiders own $1.5%
$NVAX $SNY $PFE
$NVAX
Shah Capital, holding about 8.95% of shares, has been vocal since 2024 about pushing for a board shakeup and sale, arguing the company could fetch $5-16 billion ($30-100+ per share) in a buyout far above its current valuation and that its tech would thrive under Big Pharma
#Novavax $NVAX
Partners
➡️ #Sanofi $SNY $1.2B & 4.9% stake
➡️ #Pfizer $PFE $500M & royalties
➡️ #Takeda $TAK Exclusive license
➡️ #SerumInstituteOfIndia R21/Malaria Vaccine
➡️ #SKbioscience 7% stake
➡️ #Mabion
➡️ #EmergentBioSolutions
➡️ #OxfordUniversity
#Novavax $NVAX
Partners
➡️ #Sanofi $SNY $1.2B & 4.9% stake
➡️ #Pfizer $PFE $500M & royalties
➡️ #Takeda $TAK Exclusive license
➡️ #SerumInstituteOfIndia R21/Malaria Vaccine
➡️ #SKbioscience 7% stake
➡️ #Mabion
➡️ #EmergentBioSolutions
➡️ #OxfordUniversity
#IDTBiologika has been selected, together with #SKbioscience &#Vaxxas, for an EU-funded next-generation #influenza #vaccine program.
🔗PR: https://t.co/ge3tt5ntxt
#CDMO #EUFunding @EU_HaDEA #EU4Health
PM Anutin met SK Bioscience CEO Ahn Jaeyong and Chey Tae-Won to advance Thailand–Korea vaccine cooperation.
See more: https://t.co/fW8KJuNgLB
#NBTWorld #AnutinCharnvirakul #SKBioscience #VaccineDevelopment #ThailandKorea
นายกฯ หารือ SK bioscience เสริมความมั่นคงด้านวัคซีน ลดพึ่งพาต่างชาติ เพิ่มศักยภาพองค์การเภสัชกรรม รองรับการระบาดในอนาคต
อ่านต่อคลิก >>> https://t.co/Y5Z6wl9iaS
#นายกรัฐมนตรี #SKbioscience #วัคซีน
Bill Gates has met with heads of Samsung, SK and HD Hyundai, on energy, biotech and philanthropy projects.
#SMR #HDHyundai #HDHyundaiHeavyIndustries #TerraPower #HDKSOE #SKGroup #BillGates #GatesFoundation #SamsungElectronics #SKBioscience #Microsoft
https://t.co/INDR0VIkUK
🌍 #BIO2025 in Boston #TheWorldCantWait
We’re proud to be at one of the most important global events in #LifeSciences: BIO International Convention.
🤝 Meet us at Rhode Island Pavillion, Booth 2535
#GMPmanufacturing #CDMO #Vaccines #SKbioscience
Samsung Biologics is driving the foreign dominance in Korea’s biotech supply chain.
#SamsungBiologics #SamsungBioepis #CDMO #MSD #Merck #Celltrion #KoreaCreditData #ThermoFisherScientific #Sartorius #Cytiva #SKBioscience #SigmaAldrichKorea
https://t.co/AqrK4RPGkN
It was a great honor and pleasure to see you, @drjeromekim1 - keep up the great work ! Thanks to you and team @IVIHeadquarters and #SKBioscience for the warm hospitality!
Honored to present the 2025 ParkMahnHoon Award to vaccine heroes🏆
At IVI, we continue our mission to develop & deliver vaccines that save lives, building on legacy of pioneers like Prof. Van Damme, Dr. Bandyopadhyay, Ms. Trajano & Ms. Janumpalli !
https://t.co/CULM83mAgK
Very encouraging volume for $NVAX which trades an average of around 5M shares per day and today it traded 15M shares
Remember. The SI is 26.37% & combined #Sanofi / #SKbioscience own ~10% of #Novavax
Would not be surprised to see either company increase their stake in $NVAX
Probably nothing $NVAX
Let’s not forget #Sanofi and #SKbioscience collectively own 10% of all OS, in addition to @sanofi’s $1.2B investment in #Novavax
This set up is virtually identical to the Porsche / Volkswagen #shortsqueeze scenario of 2008 📈
#MOASS
$NVAX 26% short trending on Stocktwits due to H5N1 outbreaks. 🔥
Margin is calling!
$NVAX ➡️ $10 AH
26.65% SI plus #Sanofi & #SKbioscience own ~10% of #Novavax
This is the valuation @sanofi took a 4.9% stake
Staying below 5% was a strategic move b/c I believe they knew they would be acquiring more or ALL of the shares! #MarginCall
$NVAX short sellers are about to panic. #MOASS?
Last time #Novavax has this type of short interest it squeezed ~500% over the course of a month
26.65% of shares are sold short and #Sanofi and #SKbioscience collectively own ~10% of all OS. That does t include other insiders
$NVAX short sellers are about to panic. #MOASS?
Last time #Novavax has this type of short interest it squeezed ~500% over the course of a month
26.65% of shares are sold short and #Sanofi and #SKbioscience collectively own ~10% of all OS. That does t include other insiders
ABC News warns of a “quad-demic of infectious diseases.”
@Novavax
10% of $NVAX owned by #SKbioscience and #Sanofi, the six largest pharmaceutical company in the world not to mention the stock has a short position of 26.65%
#MOASS ? TBA
#Novavax 👇
#covid ✅
#flu ✅
#RSV ✅
Did I mention #Novavax has the ONLY non #mRNA 💉
@Novavax
Keep in mind between #Sanofi ➡️ $SNY and #SKbioscience they own ~10% of #Novavax ➡️ $NVAX already and they two companies work VERY intimately on vaccine development
https://t.co/I2lGcQM7VR
The two just just announced a $52M deal today
https://t.co/hANpr8uBb1
@Novavax
Keep in mind between #Sanofi ➡️ $SNY and #SKbioscience they own ~10% of #Novavax ➡️ $NVAX already and they two companies work VERY intimately on vaccine development
https://t.co/I2lGcQM7VR
The two just just announced a $52M deal today
https://t.co/hANpr8uBb1
I find it interesting that #Sanofi and #SKbioscience appear to have an intimate relationship in #vaccine development, while both companies also currently hold an approximate 5% stake in vaccine maker #Novavax
The #MatrixM adjuvant is the prize!
$NVAX
https://t.co/wVkl6QgONk
Kenya's Vaccine Manufacturing Vision Advances as delegates from SK Bioscience, AtkinsRealis and BioVax tour KEMSA
The delegation from #SKBioscience and @atkinsrealis continues their strategic visit to Kenya, this time meeting with the @Kemsa_Kenya team as part of the ongoing feasibility study for a proposed smart vaccine manufacturing facility in the country.
The meeting at KEMSA's headquarters focused on exploring potential synergies between KEMSA's mandate of medical supply distribution and the envisioned high-tech vaccine production hub. Discussions centered on streamlining supply chains, enhancing vaccine accessibility across the country, and integrating digital solutions for efficient distribution.
Dr. Serah Muteru, the General Manager of Regulatory Affairs, Product Quality, and Safety at Kenya BioVax, expressed optimism about the potential collaboration between BioVax, KEMSA, SK Bioscience, and AtkinsRealis, noting that a robust supply chain would be critical in ensuring the success of a local vaccine manufacturing facility.
"KEMSA plays a vital role in ensuring that medical supplies efficiently reach every corner of Kenya. Their expertise in distribution logistics will be integral in supporting Kenya BioVax's mission to produce and distribute vaccines locally, ensuring timely access across the country," said Dr. @Muteru03.
The visiting team from SK Bioscience, a global leader in vaccine development, and AtkinsRealis, experts in smart infrastructure, reaffirmed their commitment to assessing Kenya's capacity to host a modern, tech-driven vaccine facility. The feasibility study aims to identify logistical and operational requirements that would underpin the proposed facility's success, including partnerships with key local stakeholders like KEMSA.
As the delegation proceeds with its tour of Kenya's key health and technology institutions, including the @BioVaxInstitute and @konzatech, the insights gathered from @Kemsa_Kenya will play a crucial role in shaping the facility's design and operational strategies.
Kenya's ambition to bolster its local vaccine manufacturing capabilities is not just a strategic move, but a significant step towards achieving self-reliance in healthcare and reducing dependence on imported vaccines. This vision holds the promise of a brighter, more secure future for the nation's health.
#KenyaBioVax #KEMSA #SmartVaccineFacility #SKBioscience #AtkinsRealis #VaccineManufacturing #HealthcareSupplyChain #KenyaHealth #MedicalInnovation #VaccineAccess #AfricaHealth
Feasibility study for a smart vaccine facility underway as SK Bioscience & AtkinsRealis visit BioVax Institute & Konza Technopolis
A delegation from #SKBioscience and @at@atkinsrealis visited the @BioVaxInstitute and the @konzatech as part of an ongoing feasibility study for establishing a smart vaccine facility in Kenya. The visit aimed to explore potential collaborations and assess Kenya's capacity to host a technologically advanced vaccine manufacturing hub.
At @BioVaxInstitute , the delegation engaged with the institute's leadership, discussing strategic opportunities for local vaccine production and capacity-building initiatives. Dr. Serah Muteru, the General Manager of Regulatory Affairs, Product Quality, and Safety at Kenya BioVax, emphasized the importance of partnerships in realizing Kenya's vision of becoming a self-reliant vaccine manufacturer.
The team also toured Konza Technopolis, where they were briefed on the infrastructural and digital innovations at the hub, which aligns with the objectives of creating a state-of-the-art, tech-driven vaccine production facility. The proposed facility aims to enhance local production, promote innovation, and contribute to Africa's vaccine security.
The feasibility study, spearheaded by SK Bioscience, a global leader in vaccine manufacturing, and AtkinsRealis, known for infrastructure and project management expertise, marks a significant step in Kenya's ambition to strengthen its healthcare sector through modern vaccine technology and manufacturing capabilities. The study will continue to assess the logistical, technical, and operational aspects necessary for the establishment of this facility.
#KenyaBioVax #SmartVaccineFacility #SKBioscience #AtkinsRealis #KonzaTechnopolis #VaccineManufacturing #HealthcareInnovation #AfricaVaccineSecurity #KenyaHealth #TechDrivenHealthcare #PartnershipsInHealth
Feasibility study to establish a Smart Vaccine Manufacturing Facility Project in Kenya
A team of experts from South Korea 🇰🇷 visited the @BioVaxInstitute to conduct a comprehensive feasibility study on establishing a smart vaccine manufacturing facility in Kenya 🇰🇪. The visit marks a significant milestone in the ongoing collaboration between Kenya and South Korea in the health, innovation and biotechnology sectors. The team, comprising leading scientists, engineers, and industry specialists from #SKBioscience, @atkinsrealis and @IVIHeadquarters, aims to assess the viability of building a state-of-the-art facility that will enhance Kenya's capacity to produce vaccines locally and strengthen the country's health security.
During the visit, the Korean delegation met with officials from @BioVaxInstitute, @MOH_Kenya, @NDUKenya, @IGADsecretariat, @nqclab, @primateresearch, @kevevapi, @KEMRI_Kenya, @USPGlobalHealth , @DiscoverJKUAT, @ppbkenya and @konzatech among others. They discussed the potential benefits of a smart manufacturing facility, which could catapult Kenya into a leadership position in vaccine production. The proposed project is expected to leverage advanced technologies such as artificial intelligence and automation to streamline #vaccine production processes, increase efficiency, and reduce costs. This initiative aligns with Kenya's broader goal of becoming a regional leader in vaccine production, reducing reliance on imported vaccines and improving access to life-saving immunizations for millions of people.
The feasibility study will explore key factors such as infrastructure, regulatory frameworks, and potential partnerships with local and international stakeholders. If successful, the smart vaccine manufacturing facility could position Kenya as a hub for vaccine innovation and production in Africa, driving economic growth and improving public health outcomes across the continent. The project has received strong support from the Kenyan government and the South Korean partners, who are keen to strengthen bilateral relations through this transformative venture.
#africanvaccinemanufacturing #VaccinesforAll #SiliconSavannah
Last Seen Hashtags on Sotwe
memorynight
Seen from United States
紧缚
Seen from Japan
InnovaEx19
Seen from United States
ควยยาม
Seen from Thailand
trabzongay
Seen from Turkey
turbanliifşa
Seen from Norway
AjmanCornich
Seen from United States
森のハンバーグプレート
Seen from United States
ميقا_حصريات
Seen from Italy
UncleHowdy
Seen from Vietnam
Most Popular Users
Elon Musk 
@elonmusk
240.9M followers
Barack Obama
@barackobama
119.2M followers
Donald J. Trump
@realdonaldtrump
111.8M followers
Cristiano Ronaldo
@cristiano
111.7M followers
Narendra Modi
@narendramodi
107.1M followers
Rihanna
@rihanna
97.9M followers
NASA
@nasa
92.2M followers
Justin Bieber
@justinbieber
91.1M followers
KATY PERRY
@katyperry
88.3M followers
Taylor Swift
@taylorswift13
82.1M followers
Lady Gaga
@ladygaga
73.7M followers
Virat Kohli
@imvkohli
70.9M followers
Kim Kardashian
@kimkardashian
70.1M followers
YouTube
@youtube
68.7M followers
Bill Gates
@billgates
64.2M followers
Neymar Jr
@neymarjr
63.7M followers
The Ellen Show
@theellenshow
62.4M followers
CNN
@cnn
61.8M followers
Selena Gomez
@selenagomez
61.3M followers
X
@x
60.8M followers